By identifying the DNMT3A/miR-129-2-5p/Rac1 signaling pathway downstream of SNHG1 that is operative in advanced bladder cancer cells, we are in no way ruling out other potential pathways or components that might also mediate the activities of SNHG1. The gene discussed is SNHG1; the disease is urinary bladder cancer.